stella
beta
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer — Stella
Recruiting
Back to Metastatic Colorectal Adenocarcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(9 sites)
United States
Karmanos Cancer Institute at McLaren Bay Region, Bay City, Michigan
Karmanos Cancer Institute at McLaren Clarkston, Clarkston, Michigan
Karmanos Cancer Institute, Detroit, Michigan
Karmanos Cancer Institute at McLaren Flint, Flint, Michigan
Karmanos Cancer Institute at McLaren Greater Lansing, Lansing, Michigan
Show all 9 locations
View full record on ClinicalTrials.gov